Current and Future Burden of Periprosthetic Joint Infection from National Claim Database
10.3346/jkms.2020.35.e410
- Author:
Hong Seok KIM
1
;
Jung Wee PARK
;
Sun-Young MOON
;
Young-Kyun LEE
;
Yong-Chan HA
;
Kyung-Hoi KOO
Author Information
1. Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
- Publication Type:Original Article
- From:Journal of Korean Medical Science
2020;35(49):e410-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Periprosthetic joint infection (PJI) is the most serious complication after total joint arthroplasty. The incidence and burden of PJI in North America have been reported.There might be potential differences according to ethnics and regional practices between western countries and East Asia. Nevertheless, its incidence in East Asia remains unknown.We aimed to evaluate the incidence and economic burden of PJI in Korea and to project the future burden.
Methods:We identified numbers of total hip arthroplasties, total knee arthroplasties and PJIs in Korea from 2010 to 2018 using medical claim data of Korean Health Insurance and Review and Assessment. Annual incidence and medical cost of PJI were calculated. We projected future burden of PJI through 2030 using Quasi-poisson regression model.
Results:The annual incidence of PJI ranged from 2.3% to 2.8% and the average cost per each PJI patient ranged from $4,361 to $6,016. Total annual cost of PJI increased from $8.0 million in 2010 to $18.0 million in 2018 and was projected to exceed $57.0 million by 2030.
Conclusion:The incidence of PJI in Korea is comparable with reported PJI incidence of 2.0%–2.7% in the United States. Our findings would be used for worldwide comparison of PJI epidemiology and establishment of healthcare policies for PJI in East Asia.
